| Application no. and date | 05770286.2 (espacenet) (Federated) (European Patent Register), 20050804 | | Patent/reg. no. and date | DK/EP 1776142, 20110727 | | Publication date | 20070425 | | Priority no. and date | GB 0417487, 20040805 | | EP pub. no. and date |
EP 1776142 20070425 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | SH/HK/GP/142128 | | Inventor | DI PADOVA, Franco, E., Kluenenfeldstrasse 45
CH-4127 Birsfelden, CH,
JESCHKE, Margit, Grenzacher Str. 10
CH-4058 Basel, CH,
GRAM, Hermann, Am Bischofsacker 20
79576 Weil am Rhein, DE,
HOFSTETTER, Hans, Chrischonaweg 92
CH-4125 Riehen, CH,
RONDEAU, Jean-Michel, 2, Impasse du Pressoir
F-68170 Rixheim, FR,
VAN DEN BERG, Wim, Ridderlaan 12
NL-6584 CB Molenhoek, NL | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | C07K 16/24 (2006.01) | | Title | Antagonistiske antistoffer mod IL-17. | | Int. application no. | EP2005008470 | | Int. publication no. | WO2006013107 | | Related patent (certificate) | CA 2015 00039 | | Status | DK/EP patent med begrænsede krav | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
